FDA — authorised 22 January 1992
- Application: NDA020098
- Marketing authorisation holder: ABBVIE
- Local brand name: MIVACRON
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
🇺🇸 Mivacron in United States
FDA authorised Mivacron on 22 January 1992
Marketing authorisations
FDA
- Status: approved
Mivacron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Mivacron approved in United States?
Yes. FDA authorised it on 22 January 1992; FDA has authorised it.
Who is the marketing authorisation holder for Mivacron in United States?
ABBVIE holds the US marketing authorisation.